Five cases of interstitial lung disease after leflunomide was combined with methotrexate therapy

Interstitial lung disease (ILD) is a rare complication of methotrexate (MTX) treatment. It usually develops during the first 6 months of treatment but later occurrences have been described (1, 2). ...